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Early and accurate diagnosis of cancer is important 
to maximize the chances that a cancer can be cured 
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The genetic basis of cancer 
• The human body is composed of a multitude 
of different cell types and tissues. 
• Cancers can arise from all of these. What we 
broadly call cancer is actually a diverse 
spectrum of human diseases, a few of which 
constitute a mere nuisance while most others 
are deadly. 
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• The most common cancers in adults are 
carcinomas, derived from epithelial cells that line 
body cavities and glands.  
• Sarcomas arise from mesenchymal tissues. 
Melanomas, retinoblastomas, neuroblastomas 
and glioblastomas are derived from dividing cells 
in the ocular retina, neurons and neural glia 
respectively.  
• Lymphomas and leukemias, sometimes referred 
to as the liquid tumors, arise in the tissues that 
give rise to lymphoid and blood cells. 
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• The cancer gene theory has provided a 
framework for understanding how both 
hereditary and environmental factors 
contribute to cancers. 
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Neoplasm vs. Tumor 
• A neoplasm (literally ‘a new growth’) is any 
abnormal new growth of cells, whereas a 
tumor is a neoplasm that is associated with a 
disease state.  
• Tumors are diseases in which a population of 
genetically related cells has acquired the 
ability to proliferate abnormally. 
11 
Cancer 
• The term ‘cancer’ simply defines those tumors 
which have acquired the ability to invade 
surrounding tissues composed of normal cells. 
The distinction between a benign and a 
malignant tumor is solely based on this 
invasive capacity. If an invading malignant 
tumor reaches a blood or lymphatic vessel, a 
cancer can metastasize and grow in distant 
tissues. 
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Tumorogenesis 
• The growth of a tumor from the progeny of 
this one cell is a process known as 
tumorigenesis. 
•  As tumors grow from small, benign lesions to 
malignant and then metastatic cancers, the 
cells that compose these tumors change 
genetically and thereby acquire new 
properties. 
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Cancer gene 
• A cancer gene can be defined as a variant of a 
gene that increases cancer risk, or promotes the 
development of cancer. 
• there are two types of cells in the human body. 
• Germ cells are the cells of the reproductive system that produce 
sperm in males and oocytes in females. Somatic cells, derived from 
the Greek work for body, soma, are all other cells exclusive of the 
germ cells. Cancer genes that arise in the germ cells are said to be 
in the germline. Individuals who inherit germline cancer genes will 
carry a germline cancer gene in every cell, somatic cells and germ 
cells alike. Such individuals are aptly known as carriers. In contrast, 
cancer genes that arise in somatic cells are not passed on to 
subsequent generations. 
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• The mutations that define cancer genes can 
be acquired in three ways:  
• (1) inheritance via the germline, 
• (2) spontaneously via somatic mutation, 
• (3) via viral infection. 
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Many different alterations in genomic 
DNA can convert normal genes to 
cancer genes. 
 
• 1. Point mutation 
• 2. Chromosomal mutations 
• 3. Epigenetic  
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• Mutations in promoter elements, 
transcriptional initiation sites, intiation 
codons, polyadenylation sites and termination 
codons have also been shown to alter gene 
function. 
• All of these together account for less than 2% 
of all mutations known to cause human 
disease, including cancer. 
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Polymorphisms and cancer 
susceptibility 
• The most common form of genetic variation 
between humans is the single nucleotide 
polymorphism, or SNP (pronounced ‘snip’). 
•  When the genomic DNA sequences of two 
individual, homologous chromosomes are 
compared, SNPs occur, on average, every 1,000–
2,000 bp. It is estimated that there are about 10–
12 million different SNPs in the human 
population. Roughly 4% of SNPs occur in exons; 
most exons are within 5,000 bp of the nearest 
SNP. 
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MTHFR C677T 
• The MTHFR nucleotide at position 677 in the gene has two possibilities: C or T. C at position 677 (leading to 
an alanine at amino acid 222) is the normal allele. The 677T allele (leading to a valine substitution at amino 
acid 222) encodes a thermolabile enzyme with reduced activity. 
• Individual with two copies of 677C (677CC) have the "normal" or "wildtype" genotype. 677TT individuals 
(homozygous) are said to have mild MTHFR deficiency. 677CT individuals (heterozygotes) are almost the same 
as normal individuals because the normal MTHFR can make up for the thermolabile MTHFR. About ten 
percent of the North American population are T-homozygous for this polymorphism. There is ethnic 
variability in the frequency of the T allele – frequency in Mediterranean/Hispanics is greater than the 
frequency in Caucasians which, in turn, is greater than in Africans/African-Americans. 
• The degree of enzyme thermolability (assessed as residual activity after heat inactivation) is much greater in 
677TT individuals (18-22%) compared with 677CT (56%) and 677CC (66-67%). Individuals of 677TT are 
predisposed to mild hyperhomocysteinemia (high blood homocysteine levels), because they have less active 
MTHFR available to produce 5-methyltetrahydrofolate (which is used to decrease homocysteine). Low dietary 
intake of the vitamin folic acid can also cause mild hyperhomocysteinemia. 
• Low folate intake affects individuals with the 677TT genotype to a greater extent than those with the 
677CC/CT genotypes. 677TT (but not 677CC/CT) individuals with lower plasma folate levels are at risk for 
elevated plasma homocysteine levels. In studies of human recombinant MTHFR, the protein encoded by 677T 
loses its FAD cofactor three times faster than the wild-type protein. 5-Methyl-THF slows the rate of FAD 
release in both the wild-type and mutant enzymes, although it is to a much greater extent in the mutant 
enzyme. 677TT individuals are at a decreased risk for certain leukemias and colon cancer. 
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DNA of a normal cell 
 
• This piece of DNA is an exact copy of the DNA from which it 
came. When the parent cell divided to create two cells, the 
cell's DNA also divided, creating two identical copies of the 
original DNA.  
 
Mutation of DNA 
• Here is the same section of DNA but from another cell. If you can 
imagine that DNA is a twisted ladder, then each rung of the ladder is 
a pair of joined molecules, or a base pair. With this section of DNA, 
one of the base pairs is different from the original.  
 
This DNA has suffered a mutation, either through mis-copying (when 
its parent cell divided), or through the damaging effects of exposure 
to radiation or a chemical carcinogen. 
 
 
Genetically altered cell 
• Body cells replicate through mitosis, they respond to their 
surrounding cells and replicate only to replace other cells. 
Sometimes a genetic mutation will cause a cell and its 
descendants to reproduce even though replacement cells 
are not needed. 
 
The DNA of the cell highlighted above has a mutation that 
causes the cell to replicate even though this tissue doesn't 
need replacement cells at this time or at this place. 
 
Spread and second mutation 
• The genetically altered cells have, over time, reproduced unchecked, 
crowding out the surrounding normal cells. The growth may contain 
one million cells and be the size of a pinhead. At this point the cells 
continue to look the same as the surrounding healthy cells.  
 
After about a million divisions, there's a good chance that one of the 
new cells will have mutated further. This cell, now carrying two 
mutant genes, could have an altered appearance and be even more 
prone to reproduce unchecked. 
 
 
Third mutation 
• Not all mutations that lead to cancerous cells result in the cells 
reproducing at a faster, more uncontrolled rate. For example, a 
mutation may simply cause a cell to keep from self-destructing. All 
normal cells have surveillance mechanisms that look for damage or 
for problems with their own control systems. If such problems are 
found, the cell destroys itself. 
 
Over time and after many cell divisions, a third mutation may arise. If 
the mutation gives the cell some further advantage, that cell will 
grow more vigorously than its predecessors and thus speed up the 
growth of the tumour. 
 
Fourth mutation 
• The new type of cells grow rapidly, allowing for more 
opportunities for mutations. The next mutation 
paves the way for the development of an even more 
aggressive cancer.  
 
At this point the tumour is still contained. 
 
 
Breaking through the membrane 
• The newer, wilder cells created by another mutation are able 
to push their way through the epithelial tissue's basement 
membrane, which is a meshwork of protein that normally 
creates a barrier. The invasive cells in this tumour are no 
longer contained.  
 
At this point the cancer is still too small to be detected. 
 
 Angiogenesis 
• Often during the development of earlier stages of the tumour, or 
perhaps by the time the tumour has broken through the basement 
membrane (as pictured above), angiogenesis takes place. 
Angiogenesis is the recruitment of blood vessels from the network 
of neighbouring vessels.  
• Without blood and the nutrients it carries, a tumour would be 
unable to continue growing. With the new blood supply, however, 
the growth of the tumour accelerates; it soon contains thousand 
million cells and, now the size of a small grape, is large enough to be 
detected as a lump  
 
Invasion and dispersal 
• The tumour has now invaded the tissue beyond the basement 
membrane. 
 
Individual cells from the tumour enter into the network of 
newly formed blood vessels, using these vessels as highways 
by which they can move to other parts of the body. A tumour 
as small as a gram can send out a million tumour cells into 
blood vessels a day. 
 
Tumour cells travel 
- metastasis 
• What makes most 
tumours so lethal is their 
ability to metastasize -- 
that is, establish new 
tumour sites at other 
locations throughout the 
body. 
Secondary tumours. 
 
• Metastasis is now 
underway, as tumour 
cells from the original 
cancer growth travel 
throughout the body. 
Most of these cells will 
die soon after entering 
the blood or lymph 
circulation. 
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Chronic inflammation and cancer 
predisposition 
• Many cancers are preceded by a local inflammatory 
response to an infectious agent 
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Mutations that occur in cancers fall into two 
functional categories: 
• Drivers: mutations that are required for 
tumorigenesis 
• Passengers: mutations that merely occur 
during tumorigenesis and do not contribute to 
the process. 
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Genetic alterations drive colorectal 
tumorigenesis 
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